- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Cambridge Major Laboratories acquires ChemShop
Cambridge Major Laboratories has acquired ChemShop BV, a supplier of API development services, and plans to invest millions of dollars to expand the company's facilities.
Cambridge Major Laboratories (US) has acquired ChemShop BV (the Netherlands), a supplier of API development services. The newly combined company has over 140 employees at 3 sites in the US and Europe. ChemShop will adopt the name Cambridge Major Laboratories Europe.
All of ChemShop's management and personnel will continue to operate the business at the pre-existing Weert (Netherlands) facility, which includes R&D laboratories, GMP kilo lab suites, and a GMP pilot plant.
Cambridge Major plans to invest several million dollars to expand the European site to include more reactor capacity, laboratories, and expansion of the company's high potency API ("HPAPI") manufacturing capabilities. The planned expansion will commence immediately and be completed in the second half of 2008.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
